- Home
- VALN vs ECX Comparison
VALN vs ECX Comparison
Compare VALN & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- ECX
- Stock Information
- Founded
- VALN 2012
- ECX 2017
- Country
- VALN France
- ECX China
- Employees
- VALN N/A
- ECX N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- ECX EDP Services
- Sector
- VALN Health Care
- ECX Technology
- Exchange
- VALN Nasdaq
- ECX Nasdaq
- Market Cap
- VALN 669.2M
- ECX 589.5M
- IPO Year
- VALN 2021
- ECX N/A
- Fundamental
- Price
- VALN $9.11
- ECX $1.55
- Analyst Decision
- VALN Strong Buy
- ECX Strong Buy
- Analyst Count
- VALN 3
- ECX 1
- Target Price
- VALN $15.33
- ECX $3.20
- AVG Volume (30 Days)
- VALN 65.5K
- ECX 6.4M
- Earning Date
- VALN 08-12-2025
- ECX 08-26-2025
- Dividend Yield
- VALN N/A
- ECX N/A
- EPS Growth
- VALN N/A
- ECX N/A
- EPS
- VALN N/A
- ECX N/A
- Revenue
- VALN $201,099,222.00
- ECX $805,604,079.00
- Revenue This Year
- VALN $18.61
- ECX $26.72
- Revenue Next Year
- VALN $25.07
- ECX $30.72
- P/E Ratio
- VALN N/A
- ECX N/A
- Revenue Growth
- VALN 21.64
- ECX 19.98
- 52 Week Low
- VALN $3.62
- ECX $0.76
- 52 Week High
- VALN $9.10
- ECX $3.25
- Technical
- Relative Strength Index (RSI)
- VALN 80.93
- ECX 43.58
- Support Level
- VALN $7.15
- ECX $1.49
- Resistance Level
- VALN $7.82
- ECX $1.68
- Average True Range (ATR)
- VALN 0.40
- ECX 0.14
- MACD
- VALN 0.14
- ECX -0.00
- Stochastic Oscillator
- VALN 99.37
- ECX 66.04
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.